Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection

Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection

Since December 2019, a pandemic caused by a new coronavirus has spread to more than 170 countries around the world. Worsening infected patients requiring intensive care unit (ICU) admission associated with 30% of mortality. A part of worsening is induced by hemostasis deregulation. The aim of this s...

Full description

Bibliographic Details
Main Authors: Paul Billoir, Kevin Alexandre, Thomas Duflot, Maxime Roger, Sébastien Miranda, Odile Goria, Luc Marie Joly, Mathieu Demeyere, Guillaume Feugray, Valery Brunel, Manuel Etienne, Véronique Le Cam Duchez
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
COVID-19
intensive care
hypercoagulability
fibrinogen
thrombin generation
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.670694/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.670694/full

Similar Items